David Katzenstein - Researcher Profile

Publications

2 shown

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

Scott M. Hammer , David Katzenstein , Michael D. Hughes +9 more

Treatment with zidovudine plus didanosine, zidovudine plus zalcitabine, or didanosine alone slows the progression of HIV disease and is superior to treatment with zidovudine alo...

1996 New England Journal of Medicine 1080 citations

The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter

David Katzenstein , Scott M. Hammer , Michael D. Hughes +9 more

Both the risk of the progression of HIV disease and the efficacy of antiretroviral therapy are strongly associated with the plasma level of HIV RNA and with the viral phenotype....

1996 New England Journal of Medicine 483 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 1,563
Institution: Stanford University

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-8593-4560

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.